PPD is a global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. The company’s clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations.
The company’s technology platform combines proprietary signal processing algorithms and NMR spectroscopic detection into a clinical analyzer to identify and quantify concentrations of lipoproteins and small molecule metabolites.
Lev is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases.
Inspire Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing ophthalmic products.
Zymed Laboratories, Inc., a biotechnology company, develops and commercializes immunochemicals in South San Francisco, California. It develops, manufactures, and markets reagents and reagent systems for life science research, clinical research, and cancer diagnostics.
Covis provides patients with a portfolio of products that are affordable and therapeutically equivalent to medications of select brands.
SunLink currently holds investments in one community hospital, two nursing home facilities, a healthcare technology company, a specialty pharmacy company, and related assets.
From offices in Durham, Portland and Seattle, Echo Health Ventures invests in, builds and grows tomorrow’s great health care companies.
Nearly one in three Americans rely on Blue Cross Blue Shield companies for access to safe, quality, and affordable healthcare.
PRA is a clinical Contract Research Organization that has worked on 100+ drugs marketed across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 50+ drugs.